Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSTP1 | P09211 | 2/20 | 0.42 |
| ▸ | PGR | P06401 | 3/20 | 0.37 |
| ▸ | ESR1 | P03372 | 1/20 | 0.37 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.37 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.37 |
| ▸ | AR | P10275 | 1/20 | 0.37 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.37 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.37 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.37 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.35 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.35 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.35 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.35 |
| ▸ | GLA | P06280 | 1/20 | 0.34 |
| ▸ | GBA1 | P04062 | 1/20 | 0.33 |
| ▸ | CTSK | P43235 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 2/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16714050 | 0.94 | GSTP1 (0.41) | GSTP1PGRESR1CHRM2ADORA3 | |
| SCHEMBL4006610 | 0.86 | GLA (0.37) | PGRESR1CHRM2ADORA3AR | |
| SCHEMBL7179832 | 0.75 | GLA (0.30) | GLA | |
| SCHEMBL561717 | 0.75 | PGR (0.40) | GSTP1PGRESR1CHRM2ADORA3 | |
| SCHEMBL1695488 | 0.73 | PGR (0.42) | GSTP1PGRESR1CHRM2ADORA3 | |
| SCHEMBL11120187 | 0.73 | PGR (0.39) | GSTP1PGRESR1CHRM2ADORA3 | |
| SCHEMBL9816253 | 0.73 | PGR (0.42) | GSTP1PGRESR1CHRM2ADORA3 | |
| SCHEMBL1695480 | 0.73 | PGR (0.42) | GSTP1PGRESR1CHRM2ADORA3 | |
| SCHEMBL9333724 | 0.73 | PGR (0.42) | GSTP1PGRESR1CHRM2ADORA3 | |
| SCHEMBL9333728 | 0.73 | PGR (0.42) | GSTP1PGRESR1CHRM2ADORA3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9907762-B2 | Stabilized mutant opsin proteins | UNIVERSITY OF WASHINGTON (US) | 2018-03-06 | — | — | US | disclosed |
| US-20160045453-A1 | STABILIZED MUTANT OPSIN PROTEINS | UNIV WASHINGTON (US) | 2016-02-18 | — | — | US | disclosed |
| US-9149446-B2 | Stabilized mutant opsin proteins | UNIVERSITY OF WASHINGTON (US) | 2015-10-06 | — | — | US | disclosed |
| US-20130072443-A1 | STABILIZED MUTANT OPSIN PROTEINS | REGENTS OF THE UNIVERSITY OF MINNESOTA (US) | 2013-03-21 | — | — | US | disclosed |
| US-20120041073-A1 | STABILIZED MUTANT OPSIN PROTEINS | REGENTS OF THE UNIVERSITY OF MINNESOTA (US) | 2012-02-16 | — | — | US | disclosed |
| US-20040242704-A1 | Stabilized mutant opsin proteins | UNIVERSITY OF WASHINGTON, TECHTRANSFER - INVENTION LICENSING | 2004-12-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040242704-A1 | Stabilized mutant opsin proteins | NR2E3, CRYZ, RBP1 | GSTP1 2113/4885PGR 3957/4885ESR1 3402/4885 |
| US-20160045453-A1 | STABILIZED MUTANT OPSIN PROTEINS | NR2E3, RBP1, CRYZ | GSTP1 2740/4885PGR 3510/4885ESR1 3356/4885 |
| US-20120041073-A1 | STABILIZED MUTANT OPSIN PROTEINS | NR2E3, CRYZ, RBP1 | GSTP1 2113/4885PGR 3957/4885ESR1 3402/4885 |
| US-20130072443-A1 | STABILIZED MUTANT OPSIN PROTEINS | NR2E3, CRYZ, RBP1 | GSTP1 2113/4885PGR 3957/4885ESR1 3402/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.